Clinical utility of serum diagnostic tests for rheumatic diseases
Establishing a diagnosis of systemic rheumatic disease requires an integration of a patient's symptoms, radiological findings, and the result of biological tests. Clinicians often try to rely heavily on objective measures such as the presence of an autoantibody. Few tests are highly sensitive,...
Gespeichert in:
| Veröffentlicht in: | Revue médicale de Bruxelles 2007-09, Vol.28 (4), p.302-307 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | fre |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 307 |
|---|---|
| container_issue | 4 |
| container_start_page | 302 |
| container_title | Revue médicale de Bruxelles |
| container_volume | 28 |
| creator | Mindlin, A |
| description | Establishing a diagnosis of systemic rheumatic disease requires an integration of a patient's symptoms, radiological findings, and the result of biological tests. Clinicians often try to rely heavily on objective measures such as the presence of an autoantibody. Few tests are highly sensitive, though the antinuclear antibodies in systemic lupus erythematosus (SLE) and the erythrocyte sedimentation rate in polymyalgia rheumatica. Some tests are highly specific: anti-PR3 and anti-MPO among patients with Wegener granulomatosis (and related vasculitides), anti-ds DNA among patients with SLE and anti-CCP in rheumatoid arthritis. Medical literature may overestimate the diagnostic utility of many commonly ordered tests for rheumatic diseases. Serum rheumatologic tests are generally most usefull for confirming a clinically suspected diagnosis. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68431741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68431741</sourcerecordid><originalsourceid>FETCH-LOGICAL-p545-7efe1186b97906fc2c0edb959c4719cbf37d2e9423e504a6439dd521b6325f413</originalsourceid><addsrcrecordid>eNo1j0tLAzEcxHNQbKn9CpKTt4W8szmW4gsKvfS-ZJN_NJJ9mGwO_fZWrXMZGH4MMzdoTQiXDVfcrNC2lE9ykZJUEnmHVlQb2RIm12i3T3GMziZcl5jicsZTwAVyHbCP9n2cyhIdXqAsBYcp4_wBdbA_mY8FbIFyj26DTQW2V9-g0_PTaf_aHI4vb_vdoZmlkI2GAJS2qjfaEBUccwR8b6RxQlPj-sC1Z2AE4yCJsEpw471ktFecySAo36DHv9o5T1_1sqcbYnGQkh1hqqVTreBU_4IPV7D2A_huznGw-dz9f-bfgfJSOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68431741</pqid></control><display><type>article</type><title>Clinical utility of serum diagnostic tests for rheumatic diseases</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mindlin, A</creator><creatorcontrib>Mindlin, A</creatorcontrib><description>Establishing a diagnosis of systemic rheumatic disease requires an integration of a patient's symptoms, radiological findings, and the result of biological tests. Clinicians often try to rely heavily on objective measures such as the presence of an autoantibody. Few tests are highly sensitive, though the antinuclear antibodies in systemic lupus erythematosus (SLE) and the erythrocyte sedimentation rate in polymyalgia rheumatica. Some tests are highly specific: anti-PR3 and anti-MPO among patients with Wegener granulomatosis (and related vasculitides), anti-ds DNA among patients with SLE and anti-CCP in rheumatoid arthritis. Medical literature may overestimate the diagnostic utility of many commonly ordered tests for rheumatic diseases. Serum rheumatologic tests are generally most usefull for confirming a clinically suspected diagnosis.</description><identifier>ISSN: 0035-3639</identifier><identifier>PMID: 17958025</identifier><language>fre</language><publisher>Belgium</publisher><subject>Antibodies, Antinuclear - blood ; Autoantibodies - blood ; Biomarkers - blood ; Diagnosis, Differential ; Humans ; Lupus Erythematosus, Systemic - blood ; Lupus Erythematosus, Systemic - diagnosis ; Lupus Erythematosus, Systemic - immunology ; Polymyalgia Rheumatica - blood ; Polymyalgia Rheumatica - diagnosis ; Rheumatic Diseases - blood ; Rheumatic Diseases - diagnosis ; Sensitivity and Specificity</subject><ispartof>Revue médicale de Bruxelles, 2007-09, Vol.28 (4), p.302-307</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17958025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mindlin, A</creatorcontrib><title>Clinical utility of serum diagnostic tests for rheumatic diseases</title><title>Revue médicale de Bruxelles</title><addtitle>Rev Med Brux</addtitle><description>Establishing a diagnosis of systemic rheumatic disease requires an integration of a patient's symptoms, radiological findings, and the result of biological tests. Clinicians often try to rely heavily on objective measures such as the presence of an autoantibody. Few tests are highly sensitive, though the antinuclear antibodies in systemic lupus erythematosus (SLE) and the erythrocyte sedimentation rate in polymyalgia rheumatica. Some tests are highly specific: anti-PR3 and anti-MPO among patients with Wegener granulomatosis (and related vasculitides), anti-ds DNA among patients with SLE and anti-CCP in rheumatoid arthritis. Medical literature may overestimate the diagnostic utility of many commonly ordered tests for rheumatic diseases. Serum rheumatologic tests are generally most usefull for confirming a clinically suspected diagnosis.</description><subject>Antibodies, Antinuclear - blood</subject><subject>Autoantibodies - blood</subject><subject>Biomarkers - blood</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - blood</subject><subject>Lupus Erythematosus, Systemic - diagnosis</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>Polymyalgia Rheumatica - blood</subject><subject>Polymyalgia Rheumatica - diagnosis</subject><subject>Rheumatic Diseases - blood</subject><subject>Rheumatic Diseases - diagnosis</subject><subject>Sensitivity and Specificity</subject><issn>0035-3639</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLAzEcxHNQbKn9CpKTt4W8szmW4gsKvfS-ZJN_NJJ9mGwO_fZWrXMZGH4MMzdoTQiXDVfcrNC2lE9ykZJUEnmHVlQb2RIm12i3T3GMziZcl5jicsZTwAVyHbCP9n2cyhIdXqAsBYcp4_wBdbA_mY8FbIFyj26DTQW2V9-g0_PTaf_aHI4vb_vdoZmlkI2GAJS2qjfaEBUccwR8b6RxQlPj-sC1Z2AE4yCJsEpw471ktFecySAo36DHv9o5T1_1sqcbYnGQkh1hqqVTreBU_4IPV7D2A_huznGw-dz9f-bfgfJSOQ</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Mindlin, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200709</creationdate><title>Clinical utility of serum diagnostic tests for rheumatic diseases</title><author>Mindlin, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p545-7efe1186b97906fc2c0edb959c4719cbf37d2e9423e504a6439dd521b6325f413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2007</creationdate><topic>Antibodies, Antinuclear - blood</topic><topic>Autoantibodies - blood</topic><topic>Biomarkers - blood</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - blood</topic><topic>Lupus Erythematosus, Systemic - diagnosis</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>Polymyalgia Rheumatica - blood</topic><topic>Polymyalgia Rheumatica - diagnosis</topic><topic>Rheumatic Diseases - blood</topic><topic>Rheumatic Diseases - diagnosis</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mindlin, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revue médicale de Bruxelles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mindlin, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical utility of serum diagnostic tests for rheumatic diseases</atitle><jtitle>Revue médicale de Bruxelles</jtitle><addtitle>Rev Med Brux</addtitle><date>2007-09</date><risdate>2007</risdate><volume>28</volume><issue>4</issue><spage>302</spage><epage>307</epage><pages>302-307</pages><issn>0035-3639</issn><abstract>Establishing a diagnosis of systemic rheumatic disease requires an integration of a patient's symptoms, radiological findings, and the result of biological tests. Clinicians often try to rely heavily on objective measures such as the presence of an autoantibody. Few tests are highly sensitive, though the antinuclear antibodies in systemic lupus erythematosus (SLE) and the erythrocyte sedimentation rate in polymyalgia rheumatica. Some tests are highly specific: anti-PR3 and anti-MPO among patients with Wegener granulomatosis (and related vasculitides), anti-ds DNA among patients with SLE and anti-CCP in rheumatoid arthritis. Medical literature may overestimate the diagnostic utility of many commonly ordered tests for rheumatic diseases. Serum rheumatologic tests are generally most usefull for confirming a clinically suspected diagnosis.</abstract><cop>Belgium</cop><pmid>17958025</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0035-3639 |
| ispartof | Revue médicale de Bruxelles, 2007-09, Vol.28 (4), p.302-307 |
| issn | 0035-3639 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_68431741 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Antibodies, Antinuclear - blood Autoantibodies - blood Biomarkers - blood Diagnosis, Differential Humans Lupus Erythematosus, Systemic - blood Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - immunology Polymyalgia Rheumatica - blood Polymyalgia Rheumatica - diagnosis Rheumatic Diseases - blood Rheumatic Diseases - diagnosis Sensitivity and Specificity |
| title | Clinical utility of serum diagnostic tests for rheumatic diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A25%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20utility%20of%20serum%20diagnostic%20tests%20for%20rheumatic%20diseases&rft.jtitle=Revue%20m%C3%A9dicale%20de%20Bruxelles&rft.au=Mindlin,%20A&rft.date=2007-09&rft.volume=28&rft.issue=4&rft.spage=302&rft.epage=307&rft.pages=302-307&rft.issn=0035-3639&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68431741%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68431741&rft_id=info:pmid/17958025&rfr_iscdi=true |